Year All202620252024202320222021202020192018201720162015201420122011 Apr 20, 2026 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer Apr 16, 2026 Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 Apr 1, 2026 Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx Mar 12, 2026 Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award Mar 9, 2026 Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C Mar 4, 2026 Ardelyx to Participate in Upcoming Investor Conferences Feb 24, 2026 Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions Feb 19, 2026 Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Feb 5, 2026 Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 Feb 3, 2026 Ardelyx Receives New Patent for Tenapanor